Dr. Gina Ogilvie

April 26, 2017 3:05pm
World-renowned researcher sets her sights on ending cervical cancer.

Dr. Gina Ogilvie, Canada Research Chair in Global Control of HPV-related Disease at UBC and Senior Advisor + Assistant Director of the Women’s Health Research Institute at BC Women's Hospital, says she and her colleagues may be nearing a monumental breakthrough in women’s health – the global eradication of cervical cancer. "We have the possibility to head down that road, which is really exciting," says Ogilvie. New understanding of human papillomavirus (HPV) in the development of cervical cancer has led Ogilvie, an international expert in cervical cancer prevention and early detection research to conduct the groundbreaking new HPV Focal study which may lead to changes to cervical cancer screening approaches in the future. Ogilvie also leads the ASPIRE Project (Advances in Screening and Prevention in Reproductive Cancers) in Uganda, which provides women and health-care providers with an affordable, integrated cervical cancer screening kit – an initiative that saves thousands of women’s lives in the developing world. The system also provides an alternate screening option for Canadian women living in remote communities or otherwise unable to undergo a pelvic examination making this a truly global initiative.  The work of Ogilvie and her team has gained a stellar reputation in this field, with BC Women’s a major player.

Written b y Ann Collette

Photography by Ian Durning